Scott D. Seiwert

Suggest Changes
Learn More
BACKGROUND & AIMS Danoprevir is a potent and selective inhibitor of the hepatitis C virus (HCV) NS3/4A serine protease. The present study assessed the safety, pharmacokinetics, and antiviral activity(More)